PTGX Protagonist Therapeutics, Inc.

2d ago, source: Seeking Alpha

Protagonist Therapeutics, Inc., a biopharmaceutical company, develops peptide-based drugs for hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing ...

Protagonist Therapeutics Stock (NASDAQ:PTGX), Analyst Ratings, Price Targets, Predictions

1mon ago, source: Benzinga.com

$28.00 17.86% HC Wainwright & Co.

This Just In: Analysts Are Boosting Their Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Outlook for This Year

1mon ago, source: Yahoo Finance

Celebrations may be in order for Protagonist Therapeutics, Inc. (NASDAQ:PTGX) shareholders, with the analysts delivering a significant upgrade to their statutory estimates for the company.

Protagonist Therapeutics, Inc.: Protagonist Therapeutics Provides Update on VERIFY Patient Enrollment and Timing of Top-line Data

1mon ago, source: Finanznachrichten

2024 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") announced it has randomized 241 patients in the ongoing Phase 3 VERIFY clinical trial evaluating rusfertide in polycythemia ...

Protagonist Therapeutics, Inc. (PTGX)

10d ago, source: Yahoo Finance

This might drive the stock higher in the near term. Protagonist Therapeutics, Inc. ( NASDAQ:PTGX ) shareholders might be concerned after seeing the share price drop 10% in... On track to achieve ...

Protagonist Therapeutics Inc PTGX

7d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Protagonist Therapeutics Inc PTGX

14d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Protagonist Therapeutics Inc.

29d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Protagonist Therapeutics Inc (PTGX)

3d ago, source: Investing

Investing.com – U.S. stocks were higher after the close on Monday, as gains in the Technology, Financials and Consumer Services sectors led shares higher. At the close in NYSE, ...

Protagonist Therapeutics Inc

1mon ago, source: U.S. News & World Report

Analysts say these cheap stocks have plenty of upside.